Investing Profile

Isaac Manke

InvestorVC
Partner at Acorn Bioventures
Photo of Isaac Manke, Partner at Acorn Bioventures
cb
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
OnKure Therapeutics
Post Ipo EquityOct 2024$65M
Series CMay 2023$54M
Series BMar 2021$57M
$180M
Q32 Bio
Post Ipo EquityMar 2024$42M
Series BOct 2020$60M
$150M
Co-investors: Diyong Xu (OrbiMed), David Grayzel (Atlas Venture)
ONK Therapeutics
Series AJan 2022$22M
$22M
True North Therapeutics
Series CDec 2015$40M
$40M